Antibodies to phase related proteins in juvenile and mature Prunus avium

In the search for biochemical and molecular markers of juvenility in trees proteins have been identified which are preferentially or differentially expressed in either the juvenile or the mature phases of Prunus avium cv. Stella. These fall into two classes: those which are phase-related and those which may be affected by root-shoot distance. N-terminal amino acid sequence data from some of these proteins were used to produce polyclonal antibodies to corresponding synthetic peptides in order to determine if they could be used as markers of phase state in woody plants. Western blot analysis was performed on proteins extracted from three sources; juvenile trees, mature trees and rooted cuttings from mature trees. The results showed that the antibodies recognised differentially-expressed proteins. In particular, one antibody to a juvenile specific protein cross-reacted with a polypeptide of approx. 28 kDa which was present in greater amounts in shoot tips of juvenile P. avium cv. Stella seedlings compared with rooted cuttings of mature plants placed in the same growth environment.     

黄瓜CsERECTA基因的原核表达及其多克隆抗体制备

ERECTA基因编码一个富含亮氨酸重复序列结构的丝/苏氨酸类受体蛋白激酶,参与调控植物器官的形态建成,在株型控制及抗逆方面也有重要作用。该研究通过构建带有maltose binding protein(MBP)标签的pET21a-CsERECTA融合蛋白原核表达载体,实现了在大肠杆菌(E.coli)BL21(DE3)中的高效表达,并对诱导表达的温度、时间和IPTG浓度进行了优化。利用镍离子螯合层析纯化得到MBP-CsERECTA融合蛋白,再用rTEV蛋白酶对其进行酶切,得到CsERECTA蛋白并制备了该蛋白的多克隆抗体。结果表明,黄瓜CsERECTA蛋白以可溶和包涵体2种形式表达,低温有助于蛋白以可溶性形式大量存在。最佳诱导温度为23℃,诱导时间为6h,IPTG浓度为0.5mmol·L~(-1)。通过Western blot可检测到黄瓜内源的CsERECTA蛋白,说明制备的多可隆抗体具有较好的特异性。多克隆抗体的成功制备为进一步研究CsERECTA的功能奠定了基础。     

Targeted localized use of therapeutic antibodies: a review of non-systemic,topical and oral applications

Therapeutic antibodies provide important tools in the “medicine chest” of today’s clinician for the treatment of a range of disorders. Typically monoclonal or polyclonal antibodies are administered in large doses, either directly or indirectly into the circulation, via a systemic route which is well suited for disseminated ailments. Diseases confined within a specific localized tissue, however, may be treated more effectively and at reduced cost by a delivery system which targets directly the affected area. To explore the advantages of the local administration of antibodies, we reviewed current alternative, non-systemic delivery approaches which are in clinical use, being trialed or developed. These less conventional approaches comprise: (a) local injections, (b) topical and (c) peroral administration routes. Local delivery includes intra-ocular injections into the vitreal humor (i.e. Ranibizumab for age-related macular degeneration), subconjunctival injections (e.g. Bevacizumab for corneal neovascularization), intra-articular joint injections (i.e. anti-TNF alpha antibody for persistent inflammatory monoarthritis) and intratumoral or peritumoral injections (e.g. Ipilimumab for cancer). A range of other strategies, such as the local use of antibacterial antibodies, are also presented. Local injections of antibodies utilize doses which range from 1/10th to 1/100th of the required systemic dose therefore reducing both side-effects and treatment costs. In addition, any therapeutic antibody escaping from the local site of disease into the systemic circulation is immediately diluted within the large blood volume, further lowering the potential for unwanted effects. Needle-free topical application routes become an option when the condition is restricted locally to an external surface. The topical route may potentially be utilized in the form of eye drops for infections or corneal neovascularization or be applied to diseased skin for psoriasis, dermatitis, pyoderma gangrenosum, antibiotic resistant bacterial infections or ulcerated wounds. Diseases confined to the gastrointestinal tract can be targeted directly by applying antibody via the injection-free peroral route. The gastrointestinal tract is unusual in that its natural immuno-tolerant nature ensures the long-term safety of repeatedly ingesting heterologous antiserum or antibody materials. Without the stringent regulatory, purity and clean room requirements of manufacturing parenteral (injectable) antibodies, production costs are minimal, with the potential for more direct low-cost targeting of gastrointestinal diseases, especially with those caused by problematic antibiotic resistant or toxigenic bacteria (e.g. Clostridium difficile, Helicobacter pylori), viruses (e.g. rotavirus, norovirus) or inflammatory bowel disease (e.g. ulcerative colitis, Crohn’s disease). Use of the oral route has previously been hindered by excessive antibody digestion within the gastrointestinal tract; however, this limitation may be overcome by intelligently applying one or more strategies (i.e. decoy proteins, masking therapeutic antibody cleavage sites, pH modulation, enzyme inhibition or encapsulation). These aspects are additionally discussed in this review and novel insights also provided. With the development of new applications via local injections, topical and peroral routes, it is envisaged that an extended range of ailments will increasingly fall within the clinical scope of therapeutic antibodies further expanding this market.     

Activation of T lymphocytes by the Fc portion of immunoglobulin

T lymphocytes are stimulated to release T-cell-replacing factors in response to Fc fragments of human IgG. Lyt 1⁺23^? T cells are directly triggered to factor production by Fc subfragments, derived from intact Fc fragments by macrophage-dependent enzymatic cleavage. These factor(s) replace T cell function in two Fc-mediated immune responses; induction of polyclonal antibody synthesis, and potentiation of anti-SRBC responses.     

Differentiation of typical and atypical enteropathogenic Escherichia coli using colony immunoblot for detection of bundle‐forming pilus expression

Aims: The aim of study was to develop a colony immunoblot assay to differentiate typical from atypical enteropathogenic Escherichia coli (EPEC) by detection of bundle‐forming pilus (BFP) expression. Methods and Results: Anti‐BFP antiserum was raised in rabbits and its reactivity was confirmed by immunoelectron microscopy and by immunoblotting recognizing bundlin, the major pilus repeating subunit. The bacterial isolates tested in the colony immunoblot assay were grown in different media. Proteins from bacterial isolates were transferred to nitrocellulose membrane after treatment with phosphate buffer containing Triton X‐100, EDTA and sodium chloride salts. When 24 typical EPEC and 96 isolates including, 72 atypical EPEC, 13 Gram‐negative type IV‐expressing strains and 11 enterobacteriaceae were cultivated in Dulbecco’s Modified Eagle’s Medium agar containing fetal bovine serum or in blood agar in the presence of CaCl₂, they showed a positivity of 92 and 83%, and specificity of 96 and 97%, respectively. Conclusion: The assay enables reliable identification of BFP‐expressing isolates and contributes to the differentiation of typical and atypical EPEC. Significance and Impact of the Study: The colony immunoblot for BFP detection developed in this study combines the simplicity of an immunoserological assay with the high efficiency of testing a large number of EPEC colonies.     

Mesodermal and neural crest derived ovine tibial and mandibular osteoblasts display distinct molecular differences

Mandibular osteoblasts originate from the neural crest and deposit bone intramembranously, mesoderm derived tibial osteoblasts by endochondral mechanisms. Bone synthesized by both cell types is identical in structure, yet functional differences between the two cell types may exist. Thus, both matched juvenile and adult mandibular and tibial osteoblasts were studied regarding their proliferative capacity, their osteogenic potential and the expression of osteogenic and origin related marker genes. Juvenile tibial cells proliferated at the highest rate while juvenile mandibular cells exhibited higher ALP activity depositing more mineralized matrix. Expression of Hoxa4 in tibial cells verified their mesodermal origin, whereas very low levels in mandibular cells confirmed their ectodermal descent. Distinct differences in the expression pattern of bone development related genes (collagen type I, osteonectin, osteocalcin, Runx2, MSX1/2, TGF-β₁, BAMBI, TWIST1, β-catenin) were found between the different cell types. The distinct dissimilarities in proliferation, alkaline phosphatase activity, the expression of characteristic genes, and mineralization may aid to explain the differences in bone healing time observed in mandibular bone when compared to long bones of the extremities.     

奥利亚罗非鱼DMRT1和DMRT4抗体制备及组织表达谱分析

DMRT1和DMRT4是DMRT基因家族的成员,该家族成员与果蝇的性别决定基因和线虫性别决定基因一样,所编码的蛋白质都包含一个具有DNA结合能力的保守基序,即DM结构域,并以锌指结构与特异DNA序列相结合,在性别决定和分化发育中起调控作用。采用RT-PCR方法分别从奥利亚罗非鱼卵巢和精巢中扩增克隆出DMRT1和DMRT4全长cDNA片段,构建表达载体,在大肠杆菌中表达了BMP-DMRT4和BMP-DMRT1蛋白。经Xa切割、Amylose-sepharose柱层析纯化后作为抗原免疫新西兰白兔制备了DMRT1和DMRT4多克隆抗体,并进行纯化。对纯化多抗进行Western blot分析,结果表明获得了高特异性的DMRT1和DMRT4抗体。为了观察DMRT1和DMRT4在组织中的表达谱,首先,我们通过实时荧光定量RT-PCR检测雌雄奥利亚罗非鱼多种组织mRNA的表达,仅在卵巢和脑中检测到DMRT4,在精巢中检测到DMRT1;其次,制备了多种组织匀浆蛋白,使用纯化的抗体进行Western blot分析,仅分别在卵巢和精巢中检测到DMRT4和DMRT1蛋白的表达;制备多种奥利亚罗非鱼组织切片,使用纯化的DMRT4和DMRT1多抗进行免疫组织化学分析,发现DMRT4仅在卵巢表达,而DMRT1仅在精巢表达。这些结果有助于阐明DMRT4和DMRT1的功能及在鱼类性别调控中的作用。     

Production of Polyclonal Antibodies to the Recombinant Potato virus M (PVM) Non‐structural Triple Gene Block Protein 1 and Coat Protein

The genes encoding the coat protein (CP) and triple gene block protein 1 (TGBp1) of Potato virus M (PVM) were cloned into expression vector pET‐45b(+) (N‐terminal 6xHis tag) and expressed in E. coli Rosetta gami‐2(DE3). The purified recombinant antigens were used for raising polyclonal antibodies. The antibodies against recombinant CP were successfully used in Western blot analysis, plate‐trapped ELISA and DAS‐ELISA as a coating for PVM detection in infected potato leaf samples. The antibodies against recombinant non‐structural protein detected the TGBp1 only in Western blot analysis. This is the first report of the production of polyclonal antibodies against recombinant coat protein and TGBp1 of PVM and their use for detecting the virus.